Difficulty: Medium
Average Score: 78%
Practice
Guaifenesin promotes increased cough production by increasing and thinning mucous secretions. These actions allow patients to decrease chest congestion by coughing out secretions by which of the following mechanisms?
Correct answer
A
Rationale
In this scenario, the correct answer is A) Guaifenesin is an expectorant and has mucolytic properties. Guaifenesin works by increasing the volume and decreasing the viscosity of respiratory tract secretions, making it easier for patients to cough out mucus and clear their airways. This mechanism helps in reducing chest congestion and improving breathing.
Option B) Guaifenesin is a bronchodilator with beta adrenergic properties is incorrect because guaifenesin does not have bronchodilator properties, nor does it act on beta adrenergic receptors to dilate the bronchioles.
Option C) Guaifenesin is an anti-inflammatory that suppresses airway mucus production is incorrect as guaifenesin does not possess anti-inflammatory properties. Its primary function is to aid in the removal of mucus from the respiratory tract.
Option D) Guaifenesin is a leukotriene modifier that reduces airway edema is incorrect because guaifenesin does not act as a leukotriene modifier. Leukotriene modifiers are a different class of drugs used for managing asthma and allergic rhinitis by reducing inflammation and constriction in the airways.
Educationally, understanding the mechanism of action of medications like guaifenesin is crucial for healthcare professionals to make informed decisions when recommending treatments for patients with respiratory conditions. This knowledge helps in providing effective care and improving patient outcomes.
Option B) Guaifenesin is a bronchodilator with beta adrenergic properties is incorrect because guaifenesin does not have bronchodilator properties, nor does it act on beta adrenergic receptors to dilate the bronchioles.
Option C) Guaifenesin is an anti-inflammatory that suppresses airway mucus production is incorrect as guaifenesin does not possess anti-inflammatory properties. Its primary function is to aid in the removal of mucus from the respiratory tract.
Option D) Guaifenesin is a leukotriene modifier that reduces airway edema is incorrect because guaifenesin does not act as a leukotriene modifier. Leukotriene modifiers are a different class of drugs used for managing asthma and allergic rhinitis by reducing inflammation and constriction in the airways.
Educationally, understanding the mechanism of action of medications like guaifenesin is crucial for healthcare professionals to make informed decisions when recommending treatments for patients with respiratory conditions. This knowledge helps in providing effective care and improving patient outcomes.